Invesaro

Stocks Comparison

Enovis vs Smith & Nephew: revenue, profit, margins and growth compared

Enovis brought in $2.2B of revenue in fiscal 2025, Smith & Nephew $6.2B in fiscal 2025. Revenue changed by +6.7% at Enovis and +6.1% at Smith & Nephew on the year before, so Enovis grew faster. Enovis kept -52.7% of its revenue as net profit, Smith & Nephew 10.1%.

Side by side, latest fiscal year

ENOVSNN
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$2.2B$6.2B
Revenue growth+6.7%+6.1%
Net income-$1.2B$625M
Net margin-52.7%10.1%
Free cash flow$19.9Mn/a
Free cash flow margin0.9%n/a
Earnings per share (diluted)-$20.75$0.72
Cash$36.4M$557M
Debt$1.3B$3.1B
Price to earningsn/an/a
Market value$1.6B$13.1B
Dividend yieldn/an/a
Rank by revenue in sector#108 of 751 · Health care#56 of 751 · Health care

Over the years

Revenue
ENOV FY2018: $3.7BENOV FY2019: $3.3BENOV FY2020: $1.1BENOV FY2021: $1.4BENOV FY2022: $1.6BENOV FY2023: $1.7BENOV FY2024: $2.1BENOV FY2025: $2.2BSNN FY2018: $4.9BSNN FY2019: $5.1BSNN FY2020: $4.6BSNN FY2021: $5.2BSNN FY2022: $5.2BSNN FY2023: $5.5BSNN FY2024: $5.8BSNN FY2025: $6.2BFY18FY19FY20FY21FY22FY23FY24FY25
ENOV $2.2BSNN $6.2B
Net income
ENOV FY2018: $140.2MENOV FY2019: -$527.6MENOV FY2020: $42.6MENOV FY2021: $71.7MENOV FY2022: -$13.3MENOV FY2023: -$33.3MENOV FY2024: -$825.5MENOV FY2025: -$1.2BSNN FY2018: $663MSNN FY2019: $600MSNN FY2020: $448MSNN FY2021: $524MSNN FY2022: $223MSNN FY2023: $263MSNN FY2024: $412MSNN FY2025: $625MFY18FY19FY20FY21FY22FY23FY24FY25
ENOV -$1.2BSNN $625M
Net margin
ENOV FY2018: 3.8%ENOV FY2019: -15.9%ENOV FY2020: 3.8%ENOV FY2021: 5.0%ENOV FY2022: -0.9%ENOV FY2023: -1.9%ENOV FY2024: -39.2%ENOV FY2025: -52.7%SNN FY2018: 13.5%SNN FY2019: 11.7%SNN FY2020: 9.8%SNN FY2021: 10.1%SNN FY2022: 4.3%SNN FY2023: 4.7%SNN FY2024: 7.1%SNN FY2025: 10.1%FY18FY19FY20FY21FY22FY23FY24FY25
ENOV -52.7%SNN 10.1%
Revenue growth
ENOV FY2019: -9.3%ENOV FY2020: -66.3%ENOV FY2021: +27.3%ENOV FY2022: +9.6%ENOV FY2023: +9.2%ENOV FY2024: +23.5%ENOV FY2025: +6.7%SNN FY2019: +4.8%SNN FY2020: -11.2%SNN FY2021: +14.3%SNN FY2022: +0.1%SNN FY2023: +6.4%SNN FY2024: +4.7%SNN FY2025: +6.1%FY19FY20FY21FY22FY23FY24FY25
ENOV +6.7%SNN +6.1%
Free cash flow
ENOV FY2018: $156.7MENOV FY2019: $5.5MENOV FY2020: $187.2MENOV FY2021: $251.9MENOV FY2022: -$161.3MENOV FY2023: $12.8MENOV FY2024: -$67.2MENOV FY2025: $19.9MFY18FY19FY20FY21FY22FY23FY24FY25
ENOV $19.9MSNN

Fiscal years as each company reports them; the two may end in different months.

Questions about Enovis and Smith & Nephew

Which is bigger by revenue, Enovis or Smith & Nephew?

Smith & Nephew is bigger by revenue: $6.2B in fiscal 2025, against $2.2B for Enovis in fiscal 2025.

Which keeps more of its revenue as profit, Enovis or Smith & Nephew?

Enovis had a net margin of -52.7% in fiscal 2025; Smith & Nephew had 10.1% in fiscal 2025.

Which grew revenue faster, Enovis or Smith & Nephew?

In their latest fiscal years revenue changed by +6.7% at Enovis and +6.1% at Smith & Nephew.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies